| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/28/2002 | US6395550 Treating blood vessels with a therapeutic liquid solution by placing the tissue in an inner trough-shaped chamber, then inserting the trough into a closable outer chamber and then while closing the chamber, infuse a solution into the chamber |
| 05/28/2002 | US6395546 Generation of dopaminergic neurons from human nervous system stem cells |
| 05/28/2002 | US6395542 Exposing immortalized intestinal tract cells, with an agent that does not express tumor markers, and expresses metabolic markers and is capable of adhering in vitro to a lactic acid strain of bacterium; determine mutagenic, toxic effects |
| 05/28/2002 | US6395530 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/28/2002 | US6395525 Genetic engineered protein |
| 05/28/2002 | US6395519 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer |
| 05/28/2002 | US6395515 Directed switch-mediated DNA recombination |
| 05/28/2002 | US6395514 Polynucleotides encoding chemokineα-5 |
| 05/28/2002 | US6395511 Nuclelotide sequences coding regulatory protein; for usein treatment of bone disorders |
| 05/28/2002 | US6395510 Vertebrate apoptosis gene: compositions and methods |
| 05/28/2002 | US6395502 Method and means for modulating PGE synthase activity |
| 05/28/2002 | US6395500 Antibodies for the detection of beer spoilage lactic acid bacteria and kit employing the antibodies |
| 05/28/2002 | US6395499 Methods of identifying modulators of a DP prostaglandin receptor |
| 05/28/2002 | US6395498 Methods of identifying compounds that modulate body weight using the OB receptor |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395490 Detecting viral infection in plants; obtain sample, incubate with viral probe, detect hybridization signal, presence of signal indicates that virus infection |
| 05/28/2002 | US6395484 Generating culture of preferential proteins; obtain cells; transform cells, recover genetically engineered cells, recover preferentially expressed polypeptides |
| 05/28/2002 | US6395473 Adenoviral based promoter assay |
| 05/28/2002 | US6395472 Methods of utilizing the TT virus |
| 05/28/2002 | US6395275 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 05/28/2002 | US6394812 Vivo induction for enhanced function of isolated hepatocytes |
| 05/28/2002 | CA2092533C Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 05/23/2002 | WO2002040995A2 Method for estimating metabolic function of xenobiotic and induction thereof |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040688A2 Maize yellow stripe1 and related genes |
| 05/23/2002 | WO2002040683A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040665A2 Complementing cell lines |
| 05/23/2002 | WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | WO2002040648A1 T cell line and use thereof |
| 05/23/2002 | WO2002040647A1 Method of establishing cultures of human dendritic cells and use thereof |
| 05/23/2002 | WO2002040646A1 Generation and use of dendritic cells |
| 05/23/2002 | WO2002040645A2 Cell constructs which can be obtained from mesenschymal stem cells and cells derivable therefrom and the use thereof |
| 05/23/2002 | WO2002040644A1 Agent imparting resistance to external stimuli |
| 05/23/2002 | WO2002040640A2 Methods of using cd8+/tcr- facilitating cells (fc) for the engraftment of purified hematopoietic stem cells (hsc) |
| 05/23/2002 | WO2002040639A2 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| 05/23/2002 | WO2002040629A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040501A2 Membrane scaffold proteins |
| 05/23/2002 | WO2002040499A1 A method for generating genetically altered antigens |
| 05/23/2002 | WO2002040242A1 Electroprocessed collagen |
| 05/23/2002 | WO2002040050A1 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 05/23/2002 | WO2002039948A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002016559A8 In vivo animal model of human leukemia |
| 05/23/2002 | WO2002006324A3 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 05/23/2002 | WO2002004609A3 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 05/23/2002 | WO2002004595A3 Production of chimeric human papillomavirus |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2001095716A3 High temperature cryogenic preservation of biologically active material |
| 05/23/2002 | WO2001092484A3 Adjuvant preparation for the induction of specific immunity |
| 05/23/2002 | WO2001088103A9 Compositions and methods for tissue dedifferentiation and regeneration |
| 05/23/2002 | WO2001087346A3 Dendritic cells loaded with toxic substances |
| 05/23/2002 | WO2001085792A8 Mu-1, member of the cytokine receptor family |
| 05/23/2002 | WO2001083774A3 Novel mutated form of arginine deiminase |
| 05/23/2002 | WO2001083755A3 Human anti-cd40 antibodies and methods of making and using same |
| 05/23/2002 | WO2001083715A3 Derivation of midbrain dopaminergic neurons from embryonic stem cells |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001081549A3 Hepatocyte lineage cells derived from pluripotent stem cells |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001078753A3 Therapeutic uses for mesenchymal stromal cells |
| 05/23/2002 | WO2001078752A3 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs |
| 05/23/2002 | WO2001073028A3 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 05/23/2002 | WO2001068565A3 Chemoselective ligation by use of a phosphine |
| 05/23/2002 | WO2001064837A8 β NETRIN AND USES THEREOF |
| 05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001029197A3 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 05/23/2002 | WO2001026459A3 Flowering time modification |
| 05/23/2002 | US20020062502 Transgenic plants expressing cellulolytic enzymes |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062151 Bioengineered anterior cruciate ligament |
| 05/23/2002 | US20020062072 Enhanced biologically based chronotropic biosensing |
| 05/23/2002 | US20020062009 Monoclonal antibodies with reduced immunogenicity |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061587 Treating cardiovascular disorders and tissue; obtain tissue, incubate with cytokines, graft somatic stem cells, monitor tissue adjustment in activity |
| 05/23/2002 | US20020061586 Isolation of preferential aggregates in sample; obtain aggregates, transform, isolate aggregates expressing green fluorescent protein |
| 05/23/2002 | US20020061582 Method of stimulating the mating of microorganisms in liquid medium |
| 05/23/2002 | US20020061578 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering |
| 05/23/2002 | US20020061576 Tissue plasminogen activator-like protease |
| 05/23/2002 | US20020061570 Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction |
| 05/23/2002 | US20020061567 Nucleotide sequences coding polypeptide for use in diagnostics, forensics, gene mapping and detection of mutation |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061535 Monitoring sample for preferential particles; obtain sample, incubate on test column, wash column, incubate with probes, wash column, detect signals |
| 05/23/2002 | US20020061521 Nucleic acids, proteins, and antibodies |
| 05/23/2002 | US20020061517 Adenovirus carrying gag gene HIV vaccine |
| 05/23/2002 | US20020061513 Isolation of preferential cellular components; obtain genetically engineered cells, express vector, detect polypeptides on support, recover polypeptides |
| 05/23/2002 | US20020061310 Compositions and methods for dendritic cell-based immunotherapy |
| 05/23/2002 | US20020061309 Production of peptides in plants as N-terminal viral coat protein fusions |
| 05/23/2002 | US20020061307 Polyalkylene oxide-modified single chain polypeptides |
| 05/23/2002 | US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology |